Suha Saleh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suha Saleh has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Casilda G. Black
Department of Microbiology, Monash University, Clayton, Victoria, Australia
1 shared publication - Harini D de Silva
Department of Microbiology, Monash University, Clayton, Victoria, Australia
1 shared publication - Lina Wang
Department of Microbiology, Monash University, Clayton, Australia
1 shared publication - Magdalena Plebanski
Accelerator for Translational Research in Clinical Trials (ATRACT) Centre, School of Health and Biomedical Sciences, STEM College, RMIT University, Melbourne, VIC 3083, Australia
1 shared publication - Ross L. Coppel
Department of Microbiology, Monash University, Clayton, Australia
1 shared publication - Svetozar Kovacevic
Department of Microbiology, Monash University, Clayton, Victoria, Australia
1 shared publication
Latest Publications
- Open Access
- 16 September 2011
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1) , 266
The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes
Malaria remains a global public health challenge. It is widely believed that an effective vaccine against malaria will need to incorporate multiple antigens from the various stages of the parasite's complex life cycle. Plasmodium falciparum Merozoite Surface Protein 4 (MSP4) is a vaccine candidate that has been selected for development for inclusion in an asexual stage subunit vaccine against malaria.
- 16 September 2011
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1) , 266
Open AccessThe antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes
Malaria remains a global public health challenge. It is widely believed that an effective vaccine against malaria will need to incorporate multiple antigens from the various stages of the parasite's complex life cycle. Plasmodium falciparum Merozoite Surface Protein 4 (MSP4) is a vaccine candidate that has been selected for development for inclusion in an asexual stage subunit vaccine against malaria.